Centre de Référence des Neuropathies Périphériques Rares, Hôpital Dupuytren, CHU Limoges

Limoges

0 studies enrolling now · 1 studies all time

What they study most

Charcot-Marie-Tooth Disease Type 1A

Studies at this site

• Phase III Trial Assessing the Efficacy and Safety of PXT3003 in CMT1A Patients (PLEO-CMT) — Completed